TECH

52.69

0.50% 0.26

Dopo l'orario di chiusura: 52.69

Bio Techne Corp (TECH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$52.43

Aprire:

$52.69

Volume 24 ore:

1.60M

Relative Volume:

0.70

Capitalizzazione di mercato:

$8.24B

Reddito:

$1.22B

Utile/perdita netta:

$81.07M

Rapporto P/E:

102.49

EPS:

0.5141

Flusso di cassa netto:

$223.02M

1 W Prestazione:

+3.70%

1M Prestazione:

-8.95%

6M Prestazione:

+4.38%

1 anno Prestazione:

-12.15%

Intervallo 1D:

$52.02

$53.23

Intervallo di 1 settimana:

$50.02

$53.53

Portata 52W:

$46.01

$72.16

Bio Techne Corp Stock (TECH) Company Profile

Nome

Bio Techne Corp

Settore

Healthcare (1114)

Industria

Biotechnology (623)

Telefono

612-379-8854

Indirizzo

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Dipendente

3,100

Cinguettio

@biotechne

Prossima data di guadagno

2024-10-30

Ultimi documenti SEC

TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, ALNY, ARGX, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TECH Bio Techne Corp	52.69	8.20B	1.22B	81.07M	223.02M	0.5141
VRTX Vertex Pharmaceuticals Inc	454.97	113.96B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	78.41B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	40.85B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	42.05B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	29.99B	606.42M	-1.28B	-997.58M	-6.403

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-03	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2025-08-21	Aggiornamento	Citigroup	Neutral → Buy
2025-07-22	Ripresa	Stephens	Overweight
2025-07-09	Iniziato	TD Cowen	Buy
2025-05-30	Iniziato	Wells Fargo	Overweight
2025-04-09	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2025-03-18	Iniziato	Evercore ISI	Outperform
2025-02-19	Downgrade	Robert W. Baird	Outperform → Neutral
2024-05-22	Downgrade	Citigroup	Buy → Neutral
2024-02-08	Iniziato	Scotiabank	Sector Outperform
2024-02-02	Downgrade	Stifel	Buy → Hold
2023-12-07	Iniziato	UBS	Buy
2023-08-28	Iniziato	William Blair	Outperform
2023-01-10	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2022-12-14	Iniziato	Deutsche Bank	Buy
2022-12-12	Aggiornamento	Citigroup	Neutral → Buy
2022-12-07	Iniziato	RBC Capital Mkts	Sector Perform
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-04-25	Downgrade	Wells Fargo	Equal Weight → Underweight
2021-09-15	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-08	Aggiornamento	Stephens	Equal-Weight → Overweight
2021-02-23	Aggiornamento	Stifel	Hold → Buy
2021-01-25	Reiterato	The Benchmark Company	Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-07-15	Downgrade	Stephens	Overweight → Equal-Weight
2020-05-27	Downgrade	Stifel	Buy → Hold
2020-05-14	Iniziato	The Benchmark Company	Buy
2020-01-08	Ripresa	Stephens	Overweight
2020-01-08	Iniziato	Wells Fargo	Equal Weight
2020-01-07	Iniziato	Citigroup	Neutral
2019-11-15	Iniziato	Stifel	Buy
2019-07-02	Aggiornamento	Janney	Neutral → Buy
2019-01-14	Aggiornamento	Stephens	Equal-Weight → Overweight
2018-10-31	Downgrade	Craig Hallum	Buy → Hold
2018-10-17	Iniziato	Goldman	Neutral
2018-06-15	Iniziato	Argus	Buy
2017-07-13	Iniziato	Wells Fargo	Market Perform
2017-02-09	Iniziato	Citigroup	Buy
2017-01-18	Iniziato	Deutsche Bank	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-01-21	Reiterato	Robert W. Baird	Outperform
2013-09-20	Aggiornamento	Robert W. Baird	Neutral → Outperform

Mostra tutto

Bio Techne Corp Borsa (TECH) Ultime notizie

Mar 25, 2026

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite - The AI Journal

Mar 25, 2026

Tudor Investment Corp ET AL Purchases Shares of 242,016 Bio-Techne Corp $TECH - MarketBeat

Mar 22, 2026

JPMorgan Chase Sells Stake in Bio-Techne Corp - National Today

Mar 22, 2026

JPMorgan Chase & Co. Sells 633,738 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 22, 2026

Mar 21, 2026

38,300 Shares in Bio-Techne Corp $TECH Purchased by Covea Finance - MarketBeat

Mar 21, 2026

After a Long Reset Period, Life Science Stocks Look Set to Rebound - Morningstar

Mar 21, 2026

Mar 20, 2026

How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks - Yahoo Finance

Mar 20, 2026

ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.

Mar 20, 2026

TECH SEC FilingsBio-Techne Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 20, 2026

Bio-Techne Corp (NASDAQ:TECH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 20, 2026

Mar 19, 2026

Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch

Mar 19, 2026

Mar 18, 2026

Bio-Techne Corp. stock underperforms Monday when compared to competitors - MSN

Mar 18, 2026

Mar 17, 2026

Should You Continue to Hold Bio-Techne Stock in Your Portfolio? - Yahoo Finance

Mar 17, 2026

Risk Check: Will Bio Techne Corporation outperform the market in YEAR2026 Levels & Fast Moving Market Watchlists - baoquankhu1.vn

Mar 17, 2026

Bio-Techne stock falls on AI software concerns, TD Cowen sees buy opportunity - Investing.com

Mar 17, 2026

Mairs & Power Inc. Has $156.18 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat

Mar 17, 2026

Mar 16, 2026

April McClain Delaney makes multiple stock transactions in Bio-Techne, BJ’s Wholesale, and C.H Robinson - Investing.com Nigeria

Mar 16, 2026

Trading the Move, Not the Narrative: (TECH) Edition - Stock Traders Daily

Mar 16, 2026

Hollow Brook Wealth Management Increases Stake in Bio-Techne Corp - National Today

Mar 16, 2026